Alexander Denoon - Revision history

David at 10:28, 13 August 2013

2013-08-13T10:28:11Z

Claire Robinson at 21:51, 1 December 2012

2012-12-01T21:51:09Z

Claire Robinson at 21:50, 1 December 2012

2012-12-01T21:50:25Z

Melissa Jones at 00:19, 28 November 2012

2012-11-28T00:19:04Z

Claire Robinson at 22:29, 27 November 2012

2012-11-27T22:29:47Z

Claire Robinson at 18:33, 27 November 2012

2012-11-27T18:33:17Z

Claire Robinson at 18:31, 27 November 2012

2012-11-27T18:31:02Z

Claire Robinson at 18:25, 27 November 2012

2012-11-27T18:25:02Z

Claire Robinson: /* Affiliations */

2012-11-27T17:07:59Z

Affiliations

Claire Robinson at 17:07, 27 November 2012

2012-11-27T17:07:42Z

← Older revision		Revision as of 10:28, 13 August 2013
Line 1:		Line 1:
−	[[Alexander Denoon]] is a lawyer and owner of the London-based law practice [[Lawford Davies Denoon]].<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>	+	'''Alexander James Tod Denoon''' (born 9 February 1970) is a lawyer and owner of the London-based law practice [[Lawford Davies Denoon]].<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>

	He is a director and trustee of the [[Science Media Centre]].<ref>Companies House (2012) [http://www.powerbase.info/images/f/f1/SMC-appointments.pdf Current Appointments Report for: Science Media Centre, created 23/11/2012], obtained from Companies House 23 Nov 2012</ref><ref>Charity Commission (2012), [http://www.charity-commission.gov.uk/Accounts/Ends27/0001140827_ac_20120331_e_c.pdf Science Media Centre Trustees' Report and Accounts for period ended 31 March 2012], acc 3 Oct 2012</ref>		He is a director and trustee of the [[Science Media Centre]].<ref>Companies House (2012) [http://www.powerbase.info/images/f/f1/SMC-appointments.pdf Current Appointments Report for: Science Media Centre, created 23/11/2012], obtained from Companies House 23 Nov 2012</ref><ref>Charity Commission (2012), [http://www.charity-commission.gov.uk/Accounts/Ends27/0001140827_ac_20120331_e_c.pdf Science Media Centre Trustees' Report and Accounts for period ended 31 March 2012], acc 3 Oct 2012</ref>

@@ Line 2: / Line 2: @@
 He is a director and trustee of the [[Science Media Centre]].<ref>Companies House (2012) [http://www.powerbase.info/images/f/f1/SMC-appointments.pdf Current Appointments Report for: Science Media Centre, created 23/11/2012], obtained from Companies House 23 Nov 2012</ref><ref>Charity Commission (2012), [http://www.charity-commission.gov.uk/Accounts/Ends27/0001140827_ac_20120331_e_c.pdf Science Media Centre Trustees' Report and Accounts for period ended 31 March 2012], acc 3 Oct 2012</ref>
 According to his LinkedIn page, his "groups and associations" include groups associated with stem cell research, gene therapy and intellectual property (patents): Cell Therapy Industry group, CellFate, ELSI Subgroup, and Intellectual Property Professionals.<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>
 ==Background==
 Denoon has a BSc in human genetics and from 1998-2001 was general counsel and company secretary of [[Biotech Australia]].<ref>Lawford Davies Denoon (2012) [http://www.lawforddaviesdenoon.com/index.php?alexander-denoon Alexander Denoon], acc 3 Oct 2012</ref><ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 3 Oct 2012</ref>

@@ Line 1: / Line 1: @@
 [[Alexander Denoon]] is a lawyer and owner of the London-based law practice [[Lawford Davies Denoon]].<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>
 ==Background==
@@ Line 46: / Line 50: @@
 :LLB
 :1988–1994
 ==Contact==

@@ Line 1: / Line 1: @@
 [[Alexander Denoon]] is a lawyer and owner of the London-based law practice [[Lawford Davies Denoon]].<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>
 The [[Lawford Davies Denoon]] website describes his role as follows:
@@ Line 9: / Line 11: @@
 A ZoomInfo page of 2003 describes his duties at Biotech Australia:
-:While at Biotech Australia, his responsibilities included maintaining, managing and licensing the intellectual property of the entire portfolio that incorporated 20 different technologies covering human and animal health.Also, Denoon implemented the share and option plans for Biotech Australia, and the parent company Human Therapeutics Limited. While at Biotech Australia, Denoon conducted the initial public offering of the majority-owned subsidiary, Pi2 Limited. Associated with the float, Denoon established a corporate compliance program to reflect the greater level of reporting, disclosure and compliance generally associated with a public company.<ref>ZoomInfo (2012), [http://www.zoominfo.com/#!search/profile/person?personId=255463011&targetid=profile Alexander Denoon], acc 27 Nov 2012</ref>
+:While at Biotech Australia, his responsibilities included maintaining, managing and licensing the intellectual property of the entire portfolio that incorporated 20 different technologies covering human and animal health. Also, Denoon implemented the share and option plans for Biotech Australia, and the parent company Human Therapeutics Limited. While at Biotech Australia, Denoon conducted the initial public offering of the majority-owned subsidiary, Pi2 Limited. Associated with the float, Denoon established a corporate compliance program to reflect the greater level of reporting, disclosure and compliance generally associated with a public company.<ref>ZoomInfo (2012), [http://www.zoominfo.com/#!search/profile/person?personId=255463011&targetid=profile Alexander Denoon], acc 27 Nov 2012</ref>
-==Background==
+==Biography==
 From his LinkedIn page as at November 2012:<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>

@@ Line 9: / Line 9: @@
 A ZoomInfo page of 2003 describes his duties at Biotech Australia:
-:While at Biotech Australia, his responsibilities included maintaining, managing and licensing the intellectual property of the entire portfolio that incorporated 20 different technologies covering human and animal health.Also, Denoon implemented the share and option plans for Biotech Australia, and the parent company Human Therapeutics Limited. While at Biotech Australia, Denoon conducted the initial public offering of the majority-owned subsidiary, Pi2 Limited.Associated with the float, Denoon established a corporate compliance program to reflect the greater level of reporting, disclosure and compliance generally associated with a public company.<ref>ZoomInfo (2012), [http://www.zoominfo.com/#!search/profile/person?personId=255463011&targetid=profile Alexander Denoon], acc 27 Nov 2012</ref>
+:While at Biotech Australia, his responsibilities included maintaining, managing and licensing the intellectual property of the entire portfolio that incorporated 20 different technologies covering human and animal health.Also, Denoon implemented the share and option plans for Biotech Australia, and the parent company Human Therapeutics Limited. While at Biotech Australia, Denoon conducted the initial public offering of the majority-owned subsidiary, Pi2 Limited. Associated with the float, Denoon established a corporate compliance program to reflect the greater level of reporting, disclosure and compliance generally associated with a public company.<ref>ZoomInfo (2012), [http://www.zoominfo.com/#!search/profile/person?personId=255463011&targetid=profile Alexander Denoon], acc 27 Nov 2012</ref>
 ==Background==

← Older revision		Revision as of 18:33, 27 November 2012
Line 1:		Line 1:
−	[[Alexander Denoon]] is a lawyer and an owner of the London-based law practice [[Lawford Davies Denoon]].<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>	+	[[Alexander Denoon]] is a lawyer and owner of the London-based law practice [[Lawford Davies Denoon]].<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>

	The [[Lawford Davies Denoon]] website describes his role as follows:		The [[Lawford Davies Denoon]] website describes his role as follows:

← Older revision		Revision as of 18:25, 27 November 2012
Line 70:		Line 70:

	[[Category:GM\|Denoon, Alexander]]		[[Category:GM\|Denoon, Alexander]]
		+	[[Category:Human Genetics\|Denoon, Alexander]]

@@ Line 43: / Line 43: @@
 ==Affiliations==
-Director and a trustee of the [[Science Media Centre]].<ref>Companies House (2012) [http://www.powerbase.info/images/f/f1/SMC-appointments.pdf Current Appointments Report for: Science Media Centre, created 23/11/2012], obtained from Companies House 23 Nov 2012</ref><ref>Charity Commission (2012), [http://www.charity-commission.gov.uk/Accounts/Ends27/0001140827_ac_20120331_e_c.pdf Science Media Centre Trustees' Report and Accounts for period ended 31 March 2012], acc 3 Oct 2012</ref>
+He is a director and trustee of the [[Science Media Centre]].<ref>Companies House (2012) [http://www.powerbase.info/images/f/f1/SMC-appointments.pdf Current Appointments Report for: Science Media Centre, created 23/11/2012], obtained from Companies House 23 Nov 2012</ref><ref>Charity Commission (2012), [http://www.charity-commission.gov.uk/Accounts/Ends27/0001140827_ac_20120331_e_c.pdf Science Media Centre Trustees' Report and Accounts for period ended 31 March 2012], acc 3 Oct 2012</ref>
 According to his LinkedIn page, his "groups and associations" include groups associated with stem cell research, gene therapy and intellectual property (patents): Cell Therapy Industry group, CellFate, ELSI Subgroup, and Intellectual Property Professionals.<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>

← Older revision		Revision as of 17:07, 27 November 2012
Line 43:		Line 43:

	==Affiliations==		==Affiliations==
		+	Director and a trustee of the [[Science Media Centre]].<ref>Companies House (2012) [http://www.powerbase.info/images/f/f1/SMC-appointments.pdf Current Appointments Report for: Science Media Centre, created 23/11/2012], obtained from Companies House 23 Nov 2012</ref><ref>Charity Commission (2012), [http://www.charity-commission.gov.uk/Accounts/Ends27/0001140827_ac_20120331_e_c.pdf Science Media Centre Trustees' Report and Accounts for period ended 31 March 2012], acc 3 Oct 2012</ref>
		+
	According to his LinkedIn page, his "groups and associations" include groups associated with stem cell research, gene therapy and intellectual property (patents): Cell Therapy Industry group, CellFate, ELSI Subgroup, and Intellectual Property Professionals.<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>		According to his LinkedIn page, his "groups and associations" include groups associated with stem cell research, gene therapy and intellectual property (patents): Cell Therapy Industry group, CellFate, ELSI Subgroup, and Intellectual Property Professionals.<ref>LinkedIn, [http://www.linkedin.com/pub/alex-denoon/22/334/30b Alexander Denoon], acc 26 Nov 2012</ref>